[4-(2-DIISOPROPYLAMINOETHOXY)-BENZYLIDENE]-N-HYDROXYMETHYLSUCCINIMIDE-HYDROBROMIDE
Compound with spectra: 1 NMR
![[4-(2-DIISOPROPYLAMINOETHOXY)-BENZYLIDENE]-N-HYDROXYMETHYLSUCCINIMIDE-HYDROBROMIDE](/api/compound/FJ7te2CpR9B.png?ph=true&h=300&w=458 "[4-(2-DIISOPROPYLAMINOETHOXY)-BENZYLIDENE]-N-HYDROXYMETHYLSUCCINIMIDE-HYDROBROMIDE")
| SpectraBase Compound ID | FJ7te2CpR9B |
|---|---|
| InChI | InChI=1S/C20H28N2O4.BrH/c1-14(2)21(15(3)4)9-10-26-18-7-5-16(6-8-18)11-17-12-19(24)22(13-23)20(17)25;/h5-8,11,14-15,23H,9-10,12-13H2,1-4H3;1H/b17-11+; |
| InChIKey | GUIBVJDSNZGUTC-SJDTYFKWSA-N |
| Mol Weight | 441.37 g/mol |
| Molecular Formula | C20H29BrN2O4 |
| Exact Mass | 440.13107 g/mol |
| Parent InChIKey | LGXWDSLEKBOAMR-GZTJUZNOSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
[4-(3-DIMETHYLAMINOPROPOXY)-BENZYLIDENE]-N-HYDROXYMETHYLSUCCINIMIDE-HYDROBROMIDE
[4-(3-DIMETHYLAMINOPROPYL)-BENZYLIDENE]-N-BROMOMETHYLSUCCINIMIDE-HYDROBROMIDE
5-[4-[(4-methyl-2-oxido-furazan-2-ium-3-yl)methoxy]benzylidene]barbituric acid
5-[4-[2-[4-(Pyridin-2-yl)piperazin-1-yl]ethoxy]phenylmethylene]thiazolidin-2,4-dione
(2E)-3-(4-isopropoxyphenyl)-2-[(4-phenyl-1-piperazinyl)carbonyl]-2-propenenitrile
(5Z)-3-ethyl-5-[4-(2-propynyloxy)benzylidene]-2-thioxo-4-imidazolidinone
2,4,6(1H,3H,5H)-pyrimidinetrione, 5-[(4-hydroxyphenyl)methylene]-1-methyl-, (5E)-
5-[4-[(4-methyl-2-oxido-furazan-2-ium-3-yl)methoxy]benzylidene]-2-thioxo-hexahydropyrimidine-4,6-quinone
5-{4-[(2-chloro-6-fluorobenzyl)oxy]benzylidene}-2,4,6(1H,3H,5H)-pyrimidinetrione
1-[(2E)-3-(4-methoxyphenyl)-2-phenyl-2-propenoyl]hexahydro-1H-azepine
| Title | Journal or Book | Year |
|---|---|---|
| Syntheses and hydrolysis of basic and dibasic ampicillin esters tailored for intracellular accumulation | Bioorganic & Medicinal Chemistry | 2001 |